Rhythm Pharmaceuticals, Inc.

RYTM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$52,078$135,586$106,095$89,137
Short-Term Investments$363,974$155,444$208,393$231,428
Receivables$33,034$26,122$17,825$18,512
Inventory$0$18,872$19,316$18,741
Other Curr. Assets$45,716$24,656$17,659$8,802
Total Curr. Assets$494,802$360,680$369,288$374,200
Property Plant & Equip (Net)$0$3,559$3,829$4,109
Goodwill$0$0$0$0
Intangibles$5,533$5,747$5,960$6,174
Long-Term Investments$671$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$5,868$2,747$7,608$7,790
Total NC Assets$12,072$12,053$17,397$18,073
Other Assets$0$0$0$0
Total Assets$506,874$372,733$386,685$392,273
Liabilities
Payables$13,631$15,982$11,912$12,328
Short-Term Debt$624$3,778$0$0
Tax Payable-$52,793$0$0$0
Deferred Revenue$0$0$0$1,286
Other Curr. Liab.$90,012$44,377$46,174$43,595
Total Curr. Liab.$104,267$129,455$111,823$115,517
LT Debt$146,866$251,505$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$103,409$0$107,934$108,269
Total NC Liab.$253,790$255,186$111,773$112,207
Other Liabilities$0$0$0$0
Cap. Leases$4,139$4,191$4,063$3,938
Total Liabilities$358,057$384,641$223,596$227,724
Equity
Pref Stock$0$0$144,142$142,820
Common Stock$67$64$62$61
Retained Earnings-$1,304,372-$1,251,468-$1,204,836-$1,155,338
AOCI-$926-$2,248-$51-$39
Other Equity$0$0$0$0
Total Equity$148,817-$11,908$163,089$164,549
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$506,874$372,733$386,685$392,273
Net Debt$95,412$119,697-$106,095-$89,137
Rhythm Pharmaceuticals, Inc. (RYTM) Financial Statements & Key Stats | AlphaPilot